US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 1.480
  • +0.240+19.35%
Close Nov 6 16:00 ET
  • 1.480
  • 0.0000.00%
Post 16:41 ET
379.76MMarket Cap-1783P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.72%-38.09M
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
-45.55%-37.1M
Net income from continuing operations
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
-43.74%-70.25M
Operating gains losses
--1.39M
---1.52M
186.08%1.51M
114.98%437K
-41.32%642K
----
----
-251.38%-1.75M
-789.60%-2.92M
330.71%1.09M
Depreciation and amortization
-3.18%4.9M
-0.06%5.02M
12.38%20.25M
0.32%5.06M
10.45%5.1M
21.36%5.06M
20.06%5.03M
32.27%18.02M
10.43%5.04M
12.96%4.62M
Other non cash items
-467.70%-2.14M
129.74%595K
30.38%-4.65M
--0
-262.35%-3.23M
-81.50%582K
50.77%-2M
-244.53%-6.68M
52.14%-7.76M
775.25%1.99M
Change In working capital
-126.62%-954K
24.91%-3.24M
104.17%3.42M
103.97%1.72M
38.71%2.43M
109.44%3.58M
-80.45%-4.31M
-2,142.71%-82.02M
-1,299.36%-43.39M
-69.52%1.75M
-Change in prepaid assets
-180.17%-841K
245.83%595K
258.79%3.13M
342.90%3.15M
2.50%-664K
158.37%1.05M
-2.77%-408K
71.83%-1.97M
-636.36%-1.3M
63.56%-681K
-Change in payables and accrued expense
-100.04%-1K
1.90%-3.72M
265.20%745K
-127.11%-1.31M
137.89%3.2M
204.54%2.65M
-9.69%-3.79M
-95.60%204K
12.30%4.85M
41.98%1.35M
-Change in other current liabilities
0.88%-112K
-0.89%-113K
-110.20%-449K
-107.94%-112K
-110.34%-112K
0.00%-113K
-105.54%-112K
-73.92%4.4M
-38.40%1.41M
-88.35%1.08M
-Change in other working capital
----
----
----
----
----
----
----
-705.61%-84.65M
-1,620.17%-48.35M
100.04%1K
Cash from discontinued investing activities
Operating cash flow
2.72%-38.09M
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
-45.55%-37.1M
Investing cash flow
Cash flow from continuing investing activities
-70.57%45.01M
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
60.61%-57.09M
Net PPE purchase and sale
64.52%-331K
98.04%-30K
88.94%-2.69M
99.45%-25K
93.01%-195K
86.99%-933K
84.25%-1.53M
62.94%-24.28M
55.38%-4.58M
76.02%-2.79M
Net investment purchase and sale
-70.53%45.34M
-34.62%22.02M
1,366.19%186.73M
-296.50%-100.67M
141.59%99.87M
26.26%153.85M
-57.79%33.69M
122.71%12.74M
108.49%51.23M
-269.08%-240.15M
Cash from discontinued investing activities
Investing cash flow
-70.57%45.01M
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
60.61%-57.09M
Financing cash flow
Cash flow from continuing financing activities
-27.93%862K
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
996.42%4.76M
Net common stock issuance
----
----
--0
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
-30.82%862K
--103K
-80.17%2.2M
-7.84%882K
-98.60%72K
-49.29%1.25M
--0
17.52%11.1M
-87.07%957K
869.19%5.13M
Net other financing activities
--0
-10.14%-76K
0.87%-457K
-30.85%-123K
---215K
---50K
---69K
---461K
---94K
----
Cash from discontinued financing activities
Financing cash flow
-27.93%862K
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
996.42%4.76M
Net cash flow
Beginning cash position
14.79%125.94M
17.84%145.93M
-57.92%123.83M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
108.91%294.29M
-70.41%116.59M
-63.53%206.02M
Current changes in cash
-93.24%7.78M
-41.54%-20M
112.96%22.1M
-2,040.45%-140.57M
169.15%61.84M
781.89%114.95M
80.22%-14.13M
-211.11%-170.46M
107.27%7.24M
47.68%-89.43M
End cash Position
-40.48%133.71M
14.79%125.94M
17.84%145.93M
17.84%145.93M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
-57.92%123.83M
-70.41%116.59M
Free cash flow
4.16%-38.43M
11.94%-42.05M
14.16%-166.38M
9.34%-40.66M
5.05%-37.88M
22.15%-40.09M
17.09%-47.75M
-1.08%-193.83M
-3.15%-44.85M
-7.56%-39.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022 (Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.72%-38.09M 9.08%-42.02M 3.46%-163.69M -0.91%-40.64M -1.57%-37.69M 11.67%-39.16M 3.43%-46.21M -34.30%-169.56M -21.24%-40.27M -45.55%-37.1M
Net income from continuing operations 28.30%-45.81M 9.40%-60.67M -28.13%-234.63M -530.34%-52.93M 27.62%-50.85M -75.89%-63.89M 1.74%-66.96M 26.82%-183.12M 89.97%-8.4M -43.74%-70.25M
Operating gains losses --1.39M ---1.52M 186.08%1.51M 114.98%437K -41.32%642K ---- ---- -251.38%-1.75M -789.60%-2.92M 330.71%1.09M
Depreciation and amortization -3.18%4.9M -0.06%5.02M 12.38%20.25M 0.32%5.06M 10.45%5.1M 21.36%5.06M 20.06%5.03M 32.27%18.02M 10.43%5.04M 12.96%4.62M
Other non cash items -467.70%-2.14M 129.74%595K 30.38%-4.65M --0 -262.35%-3.23M -81.50%582K 50.77%-2M -244.53%-6.68M 52.14%-7.76M 775.25%1.99M
Change In working capital -126.62%-954K 24.91%-3.24M 104.17%3.42M 103.97%1.72M 38.71%2.43M 109.44%3.58M -80.45%-4.31M -2,142.71%-82.02M -1,299.36%-43.39M -69.52%1.75M
-Change in prepaid assets -180.17%-841K 245.83%595K 258.79%3.13M 342.90%3.15M 2.50%-664K 158.37%1.05M -2.77%-408K 71.83%-1.97M -636.36%-1.3M 63.56%-681K
-Change in payables and accrued expense -100.04%-1K 1.90%-3.72M 265.20%745K -127.11%-1.31M 137.89%3.2M 204.54%2.65M -9.69%-3.79M -95.60%204K 12.30%4.85M 41.98%1.35M
-Change in other current liabilities 0.88%-112K -0.89%-113K -110.20%-449K -107.94%-112K -110.34%-112K 0.00%-113K -105.54%-112K -73.92%4.4M -38.40%1.41M -88.35%1.08M
-Change in other working capital ---- ---- ---- ---- ---- ---- ---- -705.61%-84.65M -1,620.17%-48.35M 100.04%1K
Cash from discontinued investing activities
Operating cash flow 2.72%-38.09M 9.08%-42.02M 3.46%-163.69M -0.91%-40.64M -1.57%-37.69M 11.67%-39.16M 3.43%-46.21M -34.30%-169.56M -21.24%-40.27M -45.55%-37.1M
Investing cash flow
Cash flow from continuing investing activities -70.57%45.01M -31.60%21.99M 1,694.87%184.05M -315.85%-100.69M 274.60%99.67M 511.18%152.91M 223.09%32.15M 90.51%-11.54M 163.16%46.65M 60.61%-57.09M
Net PPE purchase and sale 64.52%-331K 98.04%-30K 88.94%-2.69M 99.45%-25K 93.01%-195K 86.99%-933K 84.25%-1.53M 62.94%-24.28M 55.38%-4.58M 76.02%-2.79M
Net investment purchase and sale -70.53%45.34M -34.62%22.02M 1,366.19%186.73M -296.50%-100.67M 141.59%99.87M 26.26%153.85M -57.79%33.69M 122.71%12.74M 108.49%51.23M -269.08%-240.15M
Cash from discontinued investing activities
Investing cash flow -70.57%45.01M -31.60%21.99M 1,694.87%184.05M -315.85%-100.69M 274.60%99.67M 511.18%152.91M 223.09%32.15M 90.51%-11.54M 163.16%46.65M 60.61%-57.09M
Financing cash flow
Cash flow from continuing financing activities -27.93%862K 139.13%27K -83.61%1.74M -12.05%759K -103.00%-143K -51.32%1.2M -102.70%-69K -97.35%10.64M -88.34%863K 996.42%4.76M
Net common stock issuance ---- ---- --0 ---- ---- ---- ---- --0 ---- ----
Proceeds from stock option exercised by employees -30.82%862K --103K -80.17%2.2M -7.84%882K -98.60%72K -49.29%1.25M --0 17.52%11.1M -87.07%957K 869.19%5.13M
Net other financing activities --0 -10.14%-76K 0.87%-457K -30.85%-123K ---215K ---50K ---69K ---461K ---94K ----
Cash from discontinued financing activities
Financing cash flow -27.93%862K 139.13%27K -83.61%1.74M -12.05%759K -103.00%-143K -51.32%1.2M -102.70%-69K -97.35%10.64M -88.34%863K 996.42%4.76M
Net cash flow
Beginning cash position 14.79%125.94M 17.84%145.93M -57.92%123.83M 145.73%286.5M 9.05%224.65M -50.78%109.71M -57.92%123.83M 108.91%294.29M -70.41%116.59M -63.53%206.02M
Current changes in cash -93.24%7.78M -41.54%-20M 112.96%22.1M -2,040.45%-140.57M 169.15%61.84M 781.89%114.95M 80.22%-14.13M -211.11%-170.46M 107.27%7.24M 47.68%-89.43M
End cash Position -40.48%133.71M 14.79%125.94M 17.84%145.93M 17.84%145.93M 145.73%286.5M 9.05%224.65M -50.78%109.71M -57.92%123.83M -57.92%123.83M -70.41%116.59M
Free cash flow 4.16%-38.43M 11.94%-42.05M 14.16%-166.38M 9.34%-40.66M 5.05%-37.88M 22.15%-40.09M 17.09%-47.75M -1.08%-193.83M -3.15%-44.85M -7.56%-39.89M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Audit Opinions -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data